Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Er-Kim Ilac
Deal Watch: Cidara Licenses US Rights To Antifungal Under FDA Review To Melinta
Cidara gets $30m up front for US rights to the weekly echinocandin candidate for candidemia and invasive candidiasis. Takeda walks away from oncolytic virus candidate licensed from Turnstone.
- Other Names / Subsidiaries
- Er-Kim Ilac Sanayi ve Ticaret A.S.
- Erkim Pharmaceuticals
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.